| Literature DB >> 32329303 |
Sema Ketenci1, Nazife Gökçe Acet2, Gökçe Elif Sarıdoğan1,3, Banu Aydın4, Hülya Cabadak4, Mehmet Zafer Gören1.
Abstract
OBJECTIVE: The timing of administration of pharmacologic agents is crucial in traumatic stress since they can either potentiate the original fear memory or may cause fear extinction depending on the phase of fear conditioning. Brain noradrenergic system has a role in fear conditioning. Data regarding the role of prazosin in traumatic stress are controversial.Entities:
Keywords: Cholinergic; Gamma-aminobuytyric acid; Glutamic acid; Glycine.; Noradrenalline; Rostral pons
Year: 2020 PMID: 32329303 PMCID: PMC7242110 DOI: 10.9758/cpn.2020.18.2.219
Source DB: PubMed Journal: Clin Psychopharmacol Neurosci ISSN: 1738-1088 Impact factor: 2.582
Fig. 1The schematic illustration of micro-dissections. There are 2 reference points on the rat skull namely; the bregma and the lambda. The inter-aural line falls 0.3 mm posterior to the lambda. The distance from bregma and interaural line is 9 mm in a 260 g Wistar rat. The coronal sections from Rat Brain Atlas [19] were used to dissect the tissues in the slices shown. The sections start at 15.70 mm and ends at 0.20 mm anterior to the interaural line. The regions were removed according to sagittal thickness of the inter-aural coordinates and coronal depths from the surface of brains.
Fig. 2The effects of physiological saline (intraperitoneal, ip) or prazosin (16 mg/kg, ip) on (A) cumulative freezing time (s; F = 11.62, df = 3, p < 0.0001), (B) fecal pellet count (F = 4.661, df = 3, p < 0.001), (C) time spent in open arms/300 s (F = 2.274, df = 3, p > 0.05), (D) open arm entries (F = 8.162, df = 3, p < 0.001) in stressed and non-stressed rats (n = 8 per group). *p < 0.05; **p < 0.01; ***p < 0.001 (Tukey’s post-hoc test).
The effect of physiological saline or prazosin treatment on noradrenalline, GABA, glycine, glutamate levels and acetylcholine esterase activity in different brain regions of rats subjected to stress
| NTs (ng/mg tissue) | Brain regions | Stress (−) | Stress (+) | Two-way ANOVA statistics (source of variation) | ||
|---|---|---|---|---|---|---|
|
|
| |||||
| Physiological saline | Prazosin | Physiological saline | Prazosin | |||
| NA | AC | 3.07 ± 0.24 | 3.70 ± 0.30 | 3.88 ± 0.22 | 3.68 ± 0.40 | Stress (df = 1, f = 6.652, |
| DH | 2.83 ± 0.13 | 2.88 ± 0.3 | 3.31 ± 0.19 | 2.80 ± 0.50 | Stress (df = 1, f = 1.058, | |
| PFC | 2.63 ± 0.4 | 3.1 ± 0.2 | 2.79 ± 0.60 | 2.85 ± 0.50 | Stress (df = 1, f = 0.02554, | |
| RP | 7.39 ± 0.23 | 3.77 ± 0.4 | 18.89 ± 3.36 | 3.50 ± 0.20 | Interaction (df = 1, f = 6.697, | |
| GABA | AC | 3.07 ± 0.24 | 3.70 ± 0.22 | 3.89 ± 0.23 | 3.68 ± 0.18 | Interaction (df = 1, f = 4.447, |
| DH | 122.90 ± 2.83 | 119.60 ± 17.10 | 126.30 ± 7.61 | 112.60 ± 13.60 | Stress (df = 1, f = 1.472, | |
| PFC | 103.10 ± 10.60 | 124.70 ± 8.10 | 110.50 ± 11.60 | 113.60 ± 4.80 | Treatment (df = 1, f = 8.300, | |
| RP | 136.20 ± 6.58 | 157.40 ± 10.10 | 129.30 ± 11.10 | 135.10 ± 12.60 | Stress (df = 1, f = 4.258, | |
| Gly | AC | 4.03 ± 0.44 | 4.60 ± 1.20 | 4.64 ± 0.57 | 4.30 ± 0.90 | Stress (df = 1, f = 0.0953, |
| DH | 5.08 ± 0.84 | 3.90 ± 1.30 | 4.67 ± 0.61 | 4.60 ± 0.60 | Stress (df = 1, f = 0.0802, | |
| PFC | 4.53 ± 1.00 | 4.15 ± 1.10 | 3.99 ± 0.70 | 4.44 ± 0.40 | Stress (df = 1, f = 0.0992, | |
| RP | 4.26 ± 0.50 | 3.30 ± 0.40 | 4.22 ± 0.38 | 4.00 ± 0.80 | Stress (df = 1, f = 0.6570, | |
| Glu | AC | 32.22 ± 2.79 | 36.00 ± 4.80 | 31.81 ± 2.28 | 38.60 ± 8.50 | Stress (df = 1, f = 0.1402, |
| DH | 31.30 ± 2.57 | 40.20 ± 10.10 | 32.91 ± 3.05 | 33.40 ± 6.20 | Stress (df = 1, f = 0.4574, | |
| PFC | 35.07 ± 8.40 | 45.25 ± 7.90 | 35.08 ± 7.20 | 36.48 ± 8.50 | Stress (df = 1, f = 0.1309, | |
| RP | 31.45 ± 1.99 | 37.00 ± 4.60 | 36.14 ± 2.29 | 40.80 ± 12.10 | Stress (df = 1, f = 0.2541, | |
| AChE A | AC | 2.76 ± 0.31 | 185.70 ± 62.00 | 31.49 ± 8.36 | 145.10 ± 62.00 | Treatment (df = 1, f = 9.948, |
| DH | 29.76 ± 19.07 | 255.00 ± 50.00 | 3.87 ± 1.00 | 174.00 ± 50.00 | Stress (df = 1, f = 3.693, | |
| PFC | 107.50 ± 16.10 | 847.80 ± 69.10 | 548.6 ± 98.80 | 648.03 ± 76.80 | Treatment (df = 1, f = 6.803, | |
| RP | 1.53 ± 0.22 | 39.10 ± 10.00 | 92.23 ± 23.75 | 175.00 ± 74.00 | Stress (df = 1, f = 9.134, | |
Values are presented as mean ± standard error of the mean.
GABA, gamma aminobutyric acid; NTs, neurotransmitters; NA, noradrenalline; Gly, glycine; Glu, glutamate; AChE A, acetylcholine esterase activity; AC, amygdaloid complex; DH, dorsal hippocampus; PFC, prefrontal cortex; RP, rostral pons.
p < 0.05, Bonferroni post-test, significantly different from others. **p < 0.01, Bonferroni post-test, significantly different from others.